Dana Lukin, MD
List of Advanced Rx Recommended For Moderate to Severe UC Expands
The AGA has released an updated guideline on pharmacologic management of adult outpatients with UC that, for the ...
FEBRUARY 4, 2025
Combination Advanced Therapy in the Treatment of Inflammatory Bowel Disease
The development of effective biologics and small molecule targeted therapies has revolutionized the treatment of ...
SEPTEMBER 5, 2024
Inpatient Monitoring May Extend Hospital Stays in Acute Severe Ulcerative Colitis
Extended inpatient monitoring in the transition from IV steroids to oral corticosteroid therapy in ASUC may be ...
JULY 25, 2024
Intestinal Ultrasound Can Guide Treatment in Pediatric Ulcerative Colitis
IUS can be a predictive tool for assessing treatment response and outcomes in pediatric ulcerative colitis ...
JULY 25, 2024
Data From Wearables Can Indicate Flares in Patients With IBD
Data collected by wearables, such as an Apple Watch, Fitbit or Oura Ring, can help uncover flares in people with UC ...
JULY 22, 2024
Advanced Therapy Combinations Show Promise in Treatment of IBD
Therapeutic strategies employing a combination of advanced therapies are starting to reveal promising outcomes in ...
JANUARY 15, 2024
Expert Picks From DDW 2023: Crohn’s Disease
In this installment of “Expert Picks” from DDW 2023, Dana Lukin, MD, PhD, discusses six of his ...
JULY 10, 2023
Meta-Analysis Shows Efficacy of Advanced Orals in IBD
Treatment with a JAK inhibitor or S1P modulator increased remission in patients with UC, and JAK inhibitors are ...
MARCH 7, 2023
Expert Picks From DDW 2022: IBD
This issue’s installment of “Expert Picks” is from Dana J. Lukin, MD, PhD, who selected his ...
OCTOBER 12, 2022
Welcome New Board Members!
Gastroenterology & Endoscopy News is honored to add two new members to our editorial advisory board.
JANUARY 13, 2021
